CIDRAP newsletters options
The authors say their findings confirm seroprevalence studies in hard-hit areas.
There is no reason to withhold well-indicated use of the drugs during the pandemic, the authors say.
The pause is standard whenever an unexplained illness occurs.
A new study in Transboundary and Emerging Disease calculated the case-fatality rate (CFR) of COVID-19 infections in 53 countries or regions that experienced a second wave—or resurgence—of coronavirus activity, and found a significantly lower death rate among all confirmed cases than in the first wave.
This is the first study to compare the CFR in the first and second waves of the pandemic.
The Infectious Diseases Society of America (IDSA) yesterday released new guidelines for the treatment of three common antibiotic-resistant pathogens.
Also, a new analysis shows COVID-19 rates are highest in US agricultural counties.
India now has the world's second-highest case count, behind the US.
Links between use of the antibiotics and increased risk of aortic bulging or rupture may not be as strong as previously reported.
Study finds no difference in rates of hospitalization, ICU admission, or mechanical ventilation.
Two more Ebola cases were confirmed in the Democratic Republic of the Congo (DRC) Equateur province outbreak, raising the total to 112, the World Health Organization (WHO) African regional office said today in a Twitter update.
A new study published in the Journal of the American Society of Nephrology shows that 46% of hospitalized adults with severe COVID-19 suffer from acute kidney injury (AKI), and AKI was associated with a 50% mortality rate.
Three studies show that parent and child well-being has taken a serious hit during the pandemic.
Two thirds of Americans say they will not get a vaccine as soon as it's available.
The WHO says 78 countries have confirmed their participation in the COVAX vaccine initiative.
Today The Lancet published the results of two nonrandomized trials (called Sputnik V) of a Russian COVID-19 vaccine candidate, which showed no serious adverse events and demonstrated that the vaccine elicited an antibody response in study participants within 21 days of administration. The phase 1/2 trials were conducted in 76 healthy adults.
An intervention to reduce antibiotic treatment for asymptomatic bacteriuria (ASB) at a Toronto hospital was safe and associated with reduced exposure to unnecessary antibiotics, Canadian researchers reported this week in Infection Control and Hospital Epidemiology.
Our weekly wrap-up of antimicrobial stewardship & antimicrobial resistance scans
Also, the Trump administration announces next steps for pulling out of the WHO, and Sanofi and GSK announce a new vaccine trial.
Depression has tripled in all groups, but especially in those with money stressors.
"We will never submit ... any vaccine before we feel that it is safe and effective."
